Skip to main content

Identification of novel epithelial ovarian cancer biomarkers by cross-laboratory microarray analysis

Journal of Huazhong University of Science and Technology [Medical Sciences] volume 30, pages 354–359 (2010)Cite this article

Summary

The purpose of this study was to pool information in epithelial ovarian cancer by combining studies using Affymetrix expression microarray datasets made at different laboratories to identify novel biomarkers. Epithelial microarray expression information across laboratories was screened and combined after preprocessing raw microarray data, then ANOVA and unpaired T test statistical analysis was performed for identifying differentially expressed genes (DEGs), followed by clustering and pathway analysis for these DEGs. In this work, we performed a combination analysis on microarrays from three different laboratories using gene expression data on ovarian cancer and obtained a list of differential expression profiles identified as potential candidate in aggressiveness of ovarian cancer. The clustering and pathway analysis explored the different molecular basis of different ovarian cancer stages and potential important regulatory pathways in ovarian cancer development. Our results showed that combination of microarray data from different laboratories in the same platforms may overcome biases derived from probe design and technical features, thereby accelerating the identification of trustworthy DEGs, and demonstrating the advantage of integrative analysis in gene expression studies on epithelial ovarian cancer research.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Gu MJ, Shi W. Current research and management of ovarian cancer in China. Chinese-German J Clin Oncol, 2002, 1(4):212–218

    Article  Google Scholar 

  2. Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol, 2005, 99(2): 267–277

    Article  CAS  PubMed  Google Scholar 

  3. Chuaqui RF, Cole KA, Emmert-Buck MR, et al. Histopathology and molecular biology of ovarian epithelial tumors. Ann Diagn Pathol, 1998, 2(3):195–207

    Article  CAS  PubMed  Google Scholar 

  4. Niloff JM, Klug TL, Zurawski VR Jr, et al. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol, 1984, 148(8):1057–1058

    CAS  PubMed  Google Scholar 

  5. Meyer T, Rustin GJ. Role of tumor markers in monitoring epithelial ovarian cancer. Br J Cancer, 2000, 2(9):1535–1538

    Google Scholar 

  6. Welsh JB, Zarrinkar PP, Sapinoso LM, et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A, 2001, 98(3):1176–1181

    Article  CAS  PubMed  Google Scholar 

  7. Santin AD, Zhan F, Bellone S, et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer, 2004, 112(1):14–25

    Article  CAS  PubMed  Google Scholar 

  8. Skubitz APN, Pambuccian SE, Argenta AP, et al. Differential gene expression identifies subgroups of ovarian carcinoma. Transl Res, 2006, 148(5):223–248

    Article  CAS  PubMed  Google Scholar 

  9. Xu L, Tan AC, Winslow RL, et al. Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics, 2008, 27,9:125

    Article  Google Scholar 

  10. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res, 2002, 30(1):207–210

    Article  CAS  PubMed  Google Scholar 

  11. Pejovic T, Yates JE, Liu HY, et al. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res, 2006, 66(18):9017–9025

    Article  CAS  PubMed  Google Scholar 

  12. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A, 1998, 95(25):14 863–14 868

    Article  CAS  Google Scholar 

  13. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol, 2003, 4(5):3

    Article  Google Scholar 

  14. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protoc, 2009, 4(1):44–57

    Article  CAS  Google Scholar 

  15. Bellone S, Siegel ER. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Int J Gynecol Cancer, 2009, 19(5):860–866

    PubMed  Google Scholar 

  16. Wei L, Xue T. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. Int J Cancer, 2009, 125(4):791–806

    Article  CAS  PubMed  Google Scholar 

  17. Rump A, Morikawa Y. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J Biol Chem, 2004, 279(10):9190–9198

    Article  CAS  PubMed  Google Scholar 

  18. Ross PL, Cheng I, Liu X, et al. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer, 2009, 9:69

    Article  PubMed  Google Scholar 

  19. Fukumoto M, Nakayama K. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma? Pathol Int, 2006, 56(5):233–239

    Article  CAS  PubMed  Google Scholar 

  20. Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res, 2008, 18(5):538–548

    Article  CAS  PubMed  Google Scholar 

  21. Tseng GC, Cheng C, Yu YP, et al. Investigating multi-cancer biomarkers and their cross-predictability in the expression profiles of multiple cancer types. Biomark Insights, 2009, 4:57–79

    PubMed  Google Scholar 

  22. Misra UK, Deedwania R, Pizzo SV. Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK. J Biol Chem, 2005, 280(28):26 278–26 286

    Article  CAS  Google Scholar 

  23. Zbroja-Sontag W. Defense proteins and immune complexes in the blood serum of women with inflammatory and neoplastic lesions of the ovary. Am J Reprod Immunol, 1983, 4(1):11–20

    CAS  PubMed  Google Scholar 

  24. Kurer MA. Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells. Mol Biol Rep, 2007, 34(4):221–224

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Molecular Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Xuefeng Jiang, Tao Zhu, Jie Yang, Shuang Li, Shuangmei Ye, Shujie Liao, Li Meng, Yunping Lu & Ding Ma

Authors
  1. Xuefeng Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tao Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuangmei Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shujie Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yunping Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ding Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ding Ma.

Additional information

These authors contributed equally to this work.

This project was supported by grants from the National Science Foundation of China (No. 30801340; No.30901586; No.30770913).

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jiang, X., Zhu, T., Yang, J. et al. Identification of novel epithelial ovarian cancer biomarkers by cross-laboratory microarray analysis. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 354–359 (2010). https://doi.org/10.1007/s11596-010-0356-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-010-0356-1

Key words

  • epithelial ovarian cancer
  • biomarkers
  • microarray analysis